Evidence map›Paper›PMID 33350010›Full record

ArticleAngewandte Chemie (International ed. in English)2021

A Ligand Selection Strategy Identifies Chemical Probes Targeting the Proteases of SARS-CoV-2.

Lilian Peñalver, Philipp Schmid, Dávid Szamosvári, Stefan Schildknecht, Christoph Globisch, Kevin Sawade, Christine Peter, Thomas Böttcher

Open access · hybridAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Lilian PeñalverDepartment of Chemistry, Konstanz Research School Chemical Biology, Zukunftskolleg, University of Konstanz, Konstanz, Germany.
Philipp SchmidDepartment of Chemistry, Konstanz Research School Chemical Biology, Zukunftskolleg, University of Konstanz, Konstanz, Germany.ORCID 0000-0002-8286-7876
Dávid SzamosváriDepartment of Chemistry, Konstanz Research School Chemical Biology, Zukunftskolleg, University of Konstanz, Konstanz, Germany.
Stefan SchildknechtIn Vitro Toxicology and Biomedicine, Department of Biology, University of Konstanz, Konstanz, Germany.
Christoph GlobischDepartment of Chemistry, University of Konstanz, Konstanz, Germany.
Kevin SawadeDepartment of Chemistry, University of Konstanz, Konstanz, Germany.
Christine PeterDepartment of Chemistry, University of Konstanz, Konstanz, Germany.
Thomas BöttcherDepartment of Chemistry, Konstanz Research School Chemical Biology, Zukunftskolleg, University of Konstanz, Konstanz, Germany.ORCID 0000-0003-0235-4825
University of Konstanz · DEUniversity of Vienna · AT

Funding

Deutsche Forschungsgemeinschaft Emmy NoetherDeutsche Forschungsgemeinschaft SFB969FP7 People: Marie-Curie Actions Zukunftskolleg Incomming Felowship (ZIF)
6 · The paper itself

Abstract

Activity-based probes are valuable tools for chemical biology. However, finding probes that specifically target the active site of an enzyme remains a challenging task. Herein, we present a ligand selection strategy that allows to rapidly tailor electrophilic probes to a target of choice and showcase its application for the two cysteine proteases of SARS-CoV-2 as proof of concept. The resulting probes were specific for the active site labeling of 3CL

Indexed as

Molecular Probe TechniquesCatalytic DomainCoronavirus 3C ProteasesCoronavirus Papain-Like ProteasesCysteine Proteinase InhibitorsHep G2 CellsHumansLigandsMolecular Docking SimulationMolecular ProbesMolecular StructureProof of Concept StudyProtein BindingSARS-CoV-2Small Molecule LibrariesStructure-Activity Relationship3C-like protease, SARS coronavirusCoronavirus 3C ProteasesCoronavirus Papain-Like ProteasesCysteine Proteinase InhibitorsLigandsMolecular Probespapain-like protease, SARS-CoV-2Small Molecule LibrariesABPPchemical probesenzyme inhibitorslabelingproteases

Identifiers

PMID33350010
PMCPMC7986205
OpenAlexW3114199385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.